Correct Answer: B. Systemic sclerosis
Systemic sclerosis (SSc) is a connective tissue disorder characterized by progressive fibrosis of skin and internal organs. The clinical triad presented here—fingertip numbness (acral involvement), facial tightening (skin fibrosis), and nucleolar ANA pattern—is pathognomonic for SSc. The nucleolar ANA pattern is the most discriminating serological finding, seen in 40–60% of SSc patients and is highly specific for this diagnosis. This pattern reflects antibodies against RNA polymerase I and III, which are concentrated in the nucleolus. Fingertip numbness in SSc results from Raynaud's phenomenon and digital ulceration, while the characteristic "mask-like" facies arises from progressive skin tightening and fibrosis. In Indian populations, SSc presents with similar features but often with more severe internal organ involvement (pulmonary fibrosis, renal crisis) at presentation. The nucleolar pattern distinguishes SSc from other ANA-positive autoimmune conditions. ANA positivity alone is non-specific, but the nucleolar pattern combined with clinical features of acral involvement and facial fibrosis makes SSc the definitive diagnosis.
Why the other options are wrong
A. Rheumatoid arthritis — RA is primarily a joint-destructive disease with symmetric polyarthritis; it does not cause facial tightening or acral numbness as primary features. While RA can be ANA-positive (in ~30% of cases), it does NOT produce the nucleolar ANA pattern. The nucleolar pattern is virtually absent in RA, making this serological finding the key discriminator. RA presents with morning stiffness and joint swelling, not skin fibrosis. C. Sjogren's syndrome — Sjogren's syndrome presents with dry mouth and dry eyes (sicca symptoms) due to lymphocytic infiltration of salivary and lacrimal glands. Although ANA-positive, Sjogren's typically shows a homogeneous or speckled ANA pattern, NOT nucleolar. Facial tightening and acral numbness are not cardinal features of Sjogren's. The nucleolar pattern is rare in Sjogren's, making this the key distinguishing feature. D. Systemic lupus erythematosus — SLE is ANA-positive but classically shows a homogeneous or speckled pattern, rarely nucleolar. SLE presents with malar rash, photosensitivity, and glomerulonephritis rather than progressive skin fibrosis and facial tightening. While SLE can cause Raynaud's phenomenon, it does not cause the characteristic mask-like facies of SSc. The nucleolar pattern is uncommon in SLE, making it an unlikely diagnosis here.
High-Yield Facts
- Nucleolar ANA pattern is highly specific for systemic sclerosis (40–60% of SSc patients) and reflects antibodies against RNA polymerase I and III.
- Acral involvement (fingertip numbness, ulceration, Raynaud's phenomenon) is a cardinal early feature of SSc, often preceding skin fibrosis.
- Mask-like facies (facial tightening and restricted mouth opening) is a pathognomonic clinical sign of advanced SSc due to progressive skin fibrosis.
- Limited cutaneous SSc (lcSSc) presents with skin involvement distal to elbows/knees; diffuse cutaneous SSc (dcSSc) involves proximal skin and carries higher risk of internal organ involvement.
- Pulmonary fibrosis and renal crisis are the leading causes of morbidity and mortality in Indian SSc patients; early screening with HRCT and renal function is essential.
Mnemonics
SSc Triad: MASK Mask-like facies (skin tightening), Acral involvement (fingertips, Raynaud's), Scle (skin fibrosis), Kidney/Lung involvement (internal organs). Use this to recall the cardinal features of SSc when you see facial tightening + acral symptoms. ANA Patterns in CTD Nucleolar = SSc (RNA polymerase), Homogeneous = SLE/drug-induced, Speckled = Sjogren's/mixed CTD, Centromere = Limited SSc (CREST). The nucleolar pattern is the SSc-specific clue.
NBE Trap
NBE may pair "ANA-positive" with SLE or RA to distract from the nucleolar pattern—the true discriminator. Students who focus only on ANA positivity without analyzing the immunofluorescence pattern will select the wrong diagnosis.
Clinical Pearl
In Indian practice, SSc often presents late with advanced skin fibrosis and internal organ involvement. Early recognition of Raynaud's phenomenon with acral ulceration and facial tightening, combined with nucleolar ANA, allows timely initiation of immunosuppression and organ-protective therapy (ACE inhibitors for renal crisis, mycophenolate for pulmonary fibrosis) to prevent irreversible damage.
_Reference: Robbins Ch. 5 (Connective Tissue Disorders); Harrison Ch. 279 (Systemic Sclerosis)_